romosozumab

noun

ro·​mo·​so·​zu·​mab ˌrō-mō-ˈsō-zü-ˌmab 

: a monoclonal antibody that inhibits the activity of sclerostin to increase bone mass and reduce bone resorption and that is administered by subcutaneous injection to treat osteoporosis

Note: Romosozumab is marketed under the trademark Evenity.